Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - Investment giant BlackRock (NYSE:BLK), Inc. has disclosed a 1.39% stake in Mural Oncology plc, according to a regulatory filing published Wednesday.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reveals that BlackRock holds 241,628 shares in the oncology-focused company. This position consists of 241,613 owned or controlled relevant securities and 15 shares through cash-settled derivatives.
The filing indicates that BlackRock engaged in a stock loan transaction involving 41,800 Mural Oncology shares on June 10.
Companies are required to disclose positions of 1% or more in Irish companies that are subject to takeover situations. The disclosure was made through a Form 8.3 filing, which is standard for opening position disclosures under Irish takeover rules.
The document did not provide information about any potential takeover offer for Mural Oncology, nor did it indicate whether BlackRock intends to increase or decrease its position.
BlackRock reported no short positions in Mural Oncology securities, according to the filing.
This information is based on a regulatory disclosure statement submitted to the Irish Takeover Panel.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.